The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). (Q35031901)

5 August 2017

1 reference

title

The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). (English)

1 reference

experimental autoimmune encephalomyelitis

5 August 2017

0 references

0 references

2

Richard M Ransohoff

1 reference

5 August 2017

Don J Mahad

1

1 reference

5 August 2017

1 February 2003

1 reference

5 August 2017

Seminars in Immunology

1 reference

5 August 2017

15

1 reference

5 August 2017

1

1 reference

5 August 2017

23-32

1 reference

Relapse, remission, and progression in multiple sclerosis

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

The pathology of multiple sclerosis: a historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Considerations in the treatment of relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokines and leukocyte traffic

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokines: immunology's high impact factors

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

The CCR5 deletion mutation fails to protect against multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

A meta-analysis of genomic screens in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokines: a new classification system and their role in immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

The human homolog of the JE gene encodes a monocyte secretory protein

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Molecular cloning of gene sequences regulated by platelet-derived growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

The MCP/eotaxin subfamily of CC chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: roles of CD4+ and CD8+ T cells and viral persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Monocyte chemoattractant protein (MCP)-1 is rapidly expressed by sympathetic ganglion neurons following axonal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Neuronal MCP-1 expression in response to remote nerve injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokines and chemotaxis of leukocytes in infectious meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Hypoxic-ischemic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokines in the CNS: plurifunctional mediators in diverse states

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Visualization of chemokine binding sites on human brain microvessels

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

The chemokine receptor CCR2 mediates the binding and internalization of monocyte chemoattractant protein-1 along brain microvessels.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Receptor-mediated endocytosis of CC-chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Distinct chemokine receptor and cytokine expression profile in secondary progressive MS

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Regulation of monocyte chemoattractant protein (MCP)-1 transcription by interferon-gamma (IFN-gamma) in human astrocytoma cells: postinduction refractory state of the gene, governed by its upstream elements

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokines as regulators of T cell differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Mouse astrocytes respond to the chemokines MCP-1 and KC, but reverse transcriptase-polymerase chain reaction does not detect mRNA for the KC or new MCP-1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Selective suppression of chemokine receptor CXCR3 expression by interferon-beta1a in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokine expression in murine experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokine expression by central nervous system resident cells and infiltrating neutrophils during experimental autoimmune encephalomyelitis in the BALB/c mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

Chemokines and chemokine receptors in CNS pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-5323%2802%2900125-2

7 January 2021

10.1016/S1044-5323(02)00125-2

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12495638